Oklahoma 2024 Regular Session

Oklahoma House Bill HB3508

Introduced
2/5/24  
Refer
2/6/24  
Report Pass
2/13/24  
Engrossed
3/18/24  
Refer
3/27/24  

Caption

Employee Group Insurance Division; transferring division to the Oklahoma Health Care Authority; effective date; emergency.

Impact

The implications of HB 3508 are multifaceted, particularly affecting how health care services and prescription protocols are managed within the state. By centralizing the Employee Group Insurance Division under the Oklahoma Health Care Authority, the bill aims to enhance oversight and potentially reduce costs associated with state employee health plans. Furthermore, the amendments to opioid prescription guidelines aim to combat abuse through more stringent control over dosages and prescribing practices, echoing national concerns about opioid addiction and misuse.

Summary

House Bill 3508 proposes a significant reorganization of the Employee Group Insurance Division in Oklahoma by transferring its responsibilities from the Office of Management and Enterprise Services to the Oklahoma Health Care Authority. This move is intended to streamline health insurance operations for state employees and improve the efficiency of service delivery. The bill amends various provisions related to employee health benefits, including definitions pertinent to the state's Telemedicine Act and the regulation of opioid prescriptions in healthcare settings.

Sentiment

General sentiment around HB 3508 appears to be supportive among proponents who believe that consolidating health benefits administration can lead to improved efficiency and better care for state employees. However, there are counterpoints regarding concerns over regulatory overreach in prescription monitoring, indicating that some stakeholders may feel the bill's provisions could limit access to necessary medications for legitimate patients.

Contention

Notable points of contention include potential pushback from healthcare providers regarding stringent regulations on prescription practices, particularly concerning opioids, which could complicate treatment frameworks for patients. Additionally, stakeholders in the employee insurance sector might voice concerns about the transition process and the implications of moving operational controls to a different governmental entity, which could lead to disruptions in service or changes in current policy administration.

Companion Bills

No companion bills found.

Similar Bills

OK HB2108

State government; Oklahoma Employee Insurance and Benefits Act; statutory references; effective date.

OK HB2584

Physicians assistants; Pharmacy Act; prescriptions for controlled dangerous substances; Physician Assistant Act; Committee; members; requirements; Public Health Code; authority for physician assistants to carry out certain functions; prescribing and administering controlled substances; supervision.

OK SB1628

Prescription drug pricing; modifying requirements of pharmacy benefits management; prohibiting prescription drug manufacturers from discriminating against certain drug pricing program. Effective date.

OK HB1082

Public health and safety; Uniform Controlled Dangerous Substances Act; process for obtaining informed consent from patients; emergency.

OK HB1082

Public health and safety; Uniform Controlled Dangerous Substances Act; process for obtaining informed consent from patients; emergency.

OK HB3965

Physician assistants; Pharmacy Act; prescriptions for controlled dangerous substances; Physician Assistant Act; committee; members; requirements; practice agreements; prescribing; emergency.

OK HB3073

Controlled dangerous substances; adding exception to opioid prescription requirements.

OK HB3369

State government; Oklahoma Employees Insurance and Benefits Act; duties and responsibilities; external review; effective date.